Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 2/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.50 |
| ▸ | GNG2 | P59768 | 1/20 | 0.50 |
| ▸ | GNB1 | P62873 | 1/20 | 0.50 |
| ▸ | PTPRC | P08575 | 1/20 | 0.49 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 3/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.46 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | MAPT | P10636 | 7/20 | 0.46 |
| ▸ | MEN1 | O00255 | 5/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.46 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.46 |
| ▸ | PABPC1 | P11940 | 1/20 | 0.44 |
| ▸ | MAP2K7 | O14733 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30606662 | 1.00 | CYP1A2 (0.50) | CYP1A2HIF1AMAPK1GNG2GNB1 | |
| SCHEMBL29378901 | 1.00 | CYP1A2 (0.50) | CYP1A2HIF1AMAPK1GNG2GNB1 | |
| SCHEMBL9012650 | 0.94 | PTPRC (0.49) | CYP1A2HIF1AMAPK1GNG2GNB1 | |
| SCHEMBL31120783 | 0.94 | PTPRC (0.49) | CYP1A2HIF1AMAPK1GNG2GNB1 | |
| SCHEMBL13500629 | 0.88 | CYP1A2 (0.42) | CYP1A2HIF1AMAPK1GNG2GNB1 | |
| SCHEMBL12126994 | 0.87 | MAPT (0.46) | CYP1A2HIF1AMAPK1GNG2GNB1 | |
| SCHEMBL29646579 | 0.84 | BCL2 (0.56) | CYP1A2HIF1AMAPK1GNG2GNB1 | |
| SCHEMBL11095238 | 0.80 | CYP1A2 (0.44) | CYP1A2HIF1AMAPK1GNG2GNB1 | |
| SCHEMBL3410445 | 0.78 | NPC1 (0.40) | CYP1A2HIF1AMAPK1GNG2GNB1 | |
| SCHEMBL4951067 | 0.78 | PTPN1 (0.43) | CYP1A2HIF1AMAPK1GNG2GNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103804163-A | Method for preparing 16,17-dialkoxyviolanthrone derivatives | UNIV BEIJING CHEMICAL | 2014-05-21 | — | — | CN | claimed |
| JP-56024454-A | — | — | None | — | — | JP | disclosed |
| US-11992627-B2 | Articles comprising markings and related methods | Access Vascular, Inc. (US) | 2024-05-28 | — | — | US | disclosed |
| EP-4368599-A1 | BULK MATERIAL, METHOD FOR PRODUCING THE BULK MATERIAL, USE OF THE BULK MATERIAL AND USE OF AN ORGANIC DYE | Knauf Performance Materials GmbH (DE) | 2024-05-15 | — | — | EP | disclosed |
| US-20230320964-A1 | METHOD AND COMPOSITION FOR COLORING A KERATINOUS SUBSTRATE USING SOLUBILIZED VAT DYES | WELLA GERMANY GMBH (DE) | 2023-10-12 | — | — | US | disclosed |
| US-20230320964-A1 | METHOD AND COMPOSITION FOR COLORING A KERATINOUS SUBSTRATE USING SOLUBILIZED VAT DYES | WELLA GERMANY GMBH (DE) | 2023-10-12 | — | — | US | disclosed |
| US-20230310300-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | HFC PRESTIGE SERVICE GERMINY GMBH (DE) | 2023-10-05 | — | — | US | disclosed |
| US-11712487-B2 | Composite embolization beads | RAIKA MEDICAL IMAGING INC. (US) | 2023-08-01 | — | — | US | disclosed |
| EP-4171500-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | Wella Germany GmbH (DE) | 2023-05-03 | — | — | EP | disclosed |
| CN-115989054-A | Articles comprising indicia and related methods | 阿塞斯血管有限公司 | 2023-04-18 | — | — | CN | disclosed |
| US-20020150678-A1 | Method of applying nanoparticles | PROCTER & GAMBLE COMPANY, THE | 2002-10-17 | — | — | US | disclosed |
| US-20020151634-A1 | Coating compositions for modifying surfaces | THE PROCTER & GAMBLE COMPANY | 2002-10-17 | — | — | US | disclosed |
| WO-2002064877-A2 | COATING COMPOSITIONS FOR MODIFYING SURFACES | THE PROCTER & GAMBLE COMPANY (US) | 2002-08-22 | — | — | WO | disclosed |
| US-20010033348-A1 | Liquid crystal color picture screen | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2001-10-25 | — | — | US | disclosed |
| EP-1136871-A2 | Colour liquid crystal display device | Philips Patentverwaltung GmbH (DE) | 2001-09-26 | — | — | EP | disclosed |
| EP-0634518-B1 | Process for producing a tinted contact lens | MENICON CO LTD (JP) | 1997-05-21 | — | — | EP | disclosed |
| EP-0634518-A1 | Process for producing a tinted contact lens | Menicon Co., Ltd. (JP) | 1995-01-18 | — | — | EP | disclosed |
| EP-0367471-A2 | Method for tinting hydrophilic plastic articles | PILKINGTON VISIONCARE HOLDINGS, INC. (US) | 1990-05-09 | — | — | EP | disclosed |
| EP-0122771-A1 | Tinted hydrogel plastic articles and method of tinting them | Softint Inc. (US) | 1984-10-24 | — | — | EP | disclosed |
| JP-S5624454-A | PREPARATION OF VAT DYE SUITABLE FOR PAD STEAM DYEING | MITSUI TOATSU CHEM INC | 1981-03-09 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230310300-A1 | HAIR COLOURING COMPOSITIONS COMPRISING A BIO-BASED POLYMER AND A CROSSLINKER | KRT18, MKI67, IK | CYP1A2 1810/4885HIF1A 3317/4885MAPK1 1157/4885 |
| US-20230320964-A1 | METHOD AND COMPOSITION FOR COLORING A KERATINOUS SUBSTRATE USING SOLUBILIZED VAT DYES | VCL, VIM, KRT18 | CYP1A2 2549/4885HIF1A 4806/4885MAPK1 4701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.